Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
New research shows that once-daily speech-stimulating medications for the treatment of ADHD in people age 6 and older are safe and effective after one year of pain treatment.
Read Full NewsProposed federal student loan caps will drive students into pricier private loans, or derail their aspirations of becoming PAs, creating professional healthcare shortages.
The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving scanning access through...
Researchers at Spain's University of Granada have developed an artificial cornea made from the scales of several fish species commonly found in markets, which could become...
Activity restriction does not appear to lower the risk for preterm birth in pregnant women with a short cervix; it may even have the opposite effect.
The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on oil facilities could cause respiratory problems.
A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, the Washington Post reported on Wednesday, citing two people familiar with the...
In patients with COPD, starting the umeclidinium-vilanterol dry powder inhaler may lower the risk for exacerbations compared with starting glycopyrrolate-formoterol or tiotropium-olodaterol inhalers.
1.
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
2.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
3.
Liquid Biopsy for Colorectal Cancer Screening Might Not Be Ready for Prime Time.
4.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
5.
Can taking vitamin D supplements every day lower the mortality rate from cancer?
1.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
2.
Nuclear Medicine's Role in Battling Women's Cancers
3.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
4.
Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment
5.
Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge